Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-03-01 @ 12:04 PM
Study NCT ID:
NCT03247569
Status:
COMPLETED
Last Update Posted:
2022-05-06
First Post:
2017-08-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)
Sponsor:
Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-09
First Submit QC Date:
None
Study First Post Date:
2017-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-05
Last Update Post Date:
2022-05-06
Last Update Post Date Type:
ACTUAL